fura-2 has been researched along with nisoldipine in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (80.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Karaki, H; Kim, BK; Mitsui, M | 1 |
| Fujie, K; Handa, H; Sakamoto, W | 1 |
| Hofmann, F; Schuster, A; Seisenberger, C; Welling, A | 1 |
| Fujinishi, A; Kuroiwa, A; Nakashima, Y; Ohba, C; Takahara, K | 1 |
| Albillos, A; Alonso, MT; Alvarez, J; Cuchillo-Ibáñez, I; G García, A; García-Sancho, J; Montero, M; Olivares, R | 1 |
5 other study(ies) available for fura-2 and nisoldipine
| Article | Year |
|---|---|
The long-term inhibitory effect of a Ca2+ channel blocker, nisoldipine, on cytosolic Ca2+ and contraction in vascular smooth muscle.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Aorta; Calcium; Calcium Channels; Fura-2; Male; Muscle Contraction; Muscle, Smooth, Vascular; Nisoldipine; Potassium; Rats; Rats, Wistar; Ultraviolet Rays; Vasodilation | 1992 |
Inhibition of prostaglandin E2 and superoxide anion production in rat peritoneal macrophages by the calcium antagonists nifedipine and nisoldipine.
Topics: Animals; Arachidonic Acid; Calcimycin; Dinoprostone; Fura-2; In Vitro Techniques; Macrophages; Male; Nifedipine; Nisoldipine; Peritoneal Cavity; Rats; Rats, Inbred Strains; Superoxides; Tetradecanoylphorbol Acetate | 1991 |
Two stable cell lines for screening of calcium channel blockers.
Topics: Benzimidazoles; Calcium Channel Blockers; Cell Line; Dihydropyridines; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Fura-2; Heart; Mibefradil; Muscle, Smooth, Vascular; Myocardium; Nisoldipine; Patch-Clamp Techniques; Polymerase Chain Reaction; Potassium; Structure-Activity Relationship; Tetrahydronaphthalenes; Transfection | 1995 |
Effects of nisoldipine on cytosolic calcium, platelet aggregation, and coagulation/fibrinolysis in patients with coronary artery disease.
Topics: 6-Ketoprostaglandin F1 alpha; Aged; Antithrombin III; beta-Thromboglobulin; Blood Coagulation; Blood Platelets; Blood Pressure; Calcium; Calcium Channel Blockers; Coronary Angiography; Coronary Disease; Cytosol; Female; Fibrin Fibrinogen Degradation Products; Fibrinolysis; Fibrinolytic Agents; Fluorescent Dyes; Fura-2; Heart Rate; Humans; Male; Nisoldipine; Peptide Hydrolases; Plasminogen Activator Inhibitor 1; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Factor 4; Thromboxane B2; Tissue Plasminogen Activator; Vasodilator Agents | 1997 |
Control of secretion by mitochondria depends on the size of the local [Ca2+] after chromaffin cell stimulation.
Topics: Adrenal Medulla; Aequorin; Animals; Caffeine; Calcium; Calcium Channel Agonists; Calcium Channel Blockers; Calcium Channels; Calcium Signaling; Cattle; Cell Membrane; Cells, Cultured; Chromaffin Cells; Fura-2; Membrane Potentials; Mitochondria; Nisoldipine; omega-Conotoxin GVIA; omega-Conotoxins; Potassium; Pyrroles; Ryanodine Receptor Calcium Release Channel | 2001 |